Hydroxychloroquine retinopathy: an emerging problem – (Eye 31, 972 (June 2017))
Hydroxychloroquine retinopathy: an emerging problem Eye 31, 972 (June 2017). doi:10.1038/eye.2016.297 Authors: M Latasiewicz, H Gourier, I H Yusuf, R Luqmani, S M Sharma & S M Downes
Occurrence and severity of upper eyelid skin contracture in facial nerve palsy – (Eye 31, 977 (June 2017))
Occurrence and severity of upper eyelid skin contracture in facial nerve palsy Eye 31, 977 (June 2017). doi:10.1038/eye.2016.306 Authors: G F Volk, K Geißler & O Guntinas-Lichius
Neovascular age-related macular degeneration: is it worthwhile treating an eye with poor visual acuity, if the visual acuity of the fellow eye is good? – (Eye 31, 978 (June 2017))
Neovascular age-related macular degeneration: is it worthwhile treating an eye with poor visual acuity, if the visual acuity of the fellow eye is good? Eye 31, 978 (June 2017). doi:10.1038/eye.2016.324 Authors: A Rasmussen, J Fuchs, L H Hansen, M Larsen, B Sander & H Lund-Andersen
Hydroxychloroquine retinopathy – (Eye 31, 828 (June 2017))
Hydroxychloroquine retinopathy Eye 31, 828 (June 2017). doi:10.1038/eye.2016.298 Authors: I H Yusuf, S Sharma, R Luqmani & S M Downes
Prevalence and the risk factors for visual impairment in age-related macular degeneration – (Eye 31, 846 (June 2017))
Prevalence and the risk factors for visual impairment in age-related macular degeneration Eye 31, 846 (June 2017). doi:10.1038/eye.2017.72 Authors: S Srinivasan, G Swaminathan, V Kulothungan, R Raman & T Sharma